Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMTA | AZN | AMGN | GILD | BMY |
| Company | Clementia Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 26.51 | 184.02 | 348.76 | 130.09 | 57.03 |
| High | 26.69 | 186.12 | 356.50 | 131.66 | 57.82 |
| Low | 26.28 | 184.02 | 347.66 | 128.92 | 56.79 |
| Latest | 26.35 | 185.95 | 349.58 | 129.16 | 57.27 |
| Change | -0.03 | +4.15 | +3.98 | -0.02 | +0.67 |
| % Change | -0.11% | +2.28% | +1.15% | -0.02% | +1.18% |
| Volume | 716,700 | 2,346,100 | 3,451,200 | 15,369,301 | 9,575,900 |
| 20-Day Average Volume | 172,105 | 1,875,300 | 2,454,940 | 7,520,435 | 11,130,025 |
| Previous Close | 26.38 | 181.80 | 345.60 | 129.18 | 56.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.13 | 184.07 | 334.80 | 131.71 | 56.96 |
| 20-Day Raw Stochastic | 58.70% | 67.16% | 80.53% | 20.04% | 50.74% |
| 20-Day Relative Strength | 75.19 | 49.11 | 56.74 | 43.01 | 49.37 |
| Weighted Alpha | +4.80 | +22.56 | +19.37 | +11.15 | +18.93 |
| Today's Opinion | 100% Buy | 8% Sell | 24% Buy | 24% Sell | 8% Buy |
| Previous Opinion | 100% Buy | 24% Sell | 16% Buy | 24% Sell | 8% Sell |
| Last Month's Opinion | 100% Buy | 8% Buy | 8% Sell | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 04/10/19 | +0.15% since 05/29/26 | +3.80% since 05/29/26 | -3.92% since 05/29/26 | +0.16% since 05/29/26 |
| Low | 26.18 on 04/15/19 | 174.60 on 06/03/26 | 322.30 on 06/02/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 26.73 on 04/15/19 | 186.12 on 06/05/26 | 356.50 on 06/05/26 | 133.99 on 06/01/26 | 57.81 on 06/05/26 |
| 1-Month | |||||
| %Chg | +1.74% since 03/15/19 | +2.60% since 05/05/26 | +6.07% since 05/05/26 | -3.24% since 05/05/26 | +0.56% since 05/05/26 |
| Low | 25.75 on 03/19/19 | 174.60 on 06/03/26 | 320.96 on 05/19/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 26.73 on 04/15/19 | 191.50 on 05/21/26 | 356.50 on 06/05/26 | 137.50 on 05/12/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | +89.43% since 01/17/19 | -5.86% since 03/05/26 | -4.90% since 03/05/26 | -11.01% since 03/05/26 | -5.71% since 03/05/26 |
| Low | 12.18 on 01/28/19 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 26.73 on 04/15/19 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 6-Month | |||||
| %Chg | +166.97% since 10/17/18 | +3.10% since 12/05/25 | +5.97% since 12/05/25 | +6.55% since 12/05/25 | +9.82% since 12/05/25 |
| Low | 9.30 on 10/22/18 | 174.60 on 06/03/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 26.73 on 04/15/19 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,002,854 | 281,955,072 | 186,523,104 | 160,386,000 | 115,581,216 |
| Shares Outstanding, K | 38,059 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -58,130,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | N/A | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.64 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/08/19 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.04 | 15.30 | 15.41 | 9.23 |